Become a co-owner from just €10 and shape the future of menstrual and reproductive health with us.
Clue Birth Control is a FDA-cleared evidence-based fertility awareness-based method (FABM) that uses a validated algorithm to provide personalized pregnancy risk predictions.
Clue Birth Control is 92% effective at preventing pregnancy when used typically and 97% effective when used perfectly.*
Clue Birth Control is for women who are 18-45 years old with cycles that are 20 to 40 days long and varied by 9 days or less over the last 12 cycles.
If the patient has recently been pregnant or on hormonal birth control or has used a copper IUD, they should wait until they have had at least 3 eligible cycles (4 periods) before using Clue Birth Control.
Clue Birth Control requires the patient to log in and document cycle day 1 (period start date) and check their risk each day before they have sex.
Clue Birth Control is an over-the-counter product. The feature evaluates your patient’s eligibility and provides all education required for safe use. We encourage our users to speak with their healthcare provider before choosing their desired birth control method.
*In the interest of providing easy-to-understand information that empowers people to make informed health decisions, when reporting efficacy figures, Clue uses the upper bound of the failure rate’s 95% confidence interval. Clinical trial results represent an estimate of the population efficacy rate. To be conservative, Clue reports the upper bound of the confidence interval from the peer-reviewed, published clinical trial of Clue Birth Control rather than the point estimate.The clinical trial found a point estimate with confidence intervals for the typical-use failure rate of 5.8% (95% confidence interval: 3.6% - 8.1%). The point estimate with confidence intervals for perfect use failure rate was 1.0% (95% confidence interval: -0.9% - 2.9%). Therefore, the marketed efficacy rates are 92% effective with typical use and 97% effective with perfect use. The Clue Birth Control clinical trial was conducted by researchers at Georgetown University in Washington, DC, and is registered at ClinicalTrials.gov as study number NCT02833922.
Introducing
Clue Birth Control
Clue Birth Control is our FDA-cleared digital contraceptive, built right into the Clue app, which your patients already trust and use to track their periods and other cycle-related symptoms.
Clue Birth Control is a technology-enhanced fertility awareness-based method (FABM) that uses a patient’s cycle data to predict high and low risk days for pregnancy. On high risk days, the patient must use condoms every time they have sex that may result in pregnancy.
Efficacy
Evidence
How it works
Eligibility
Charting a visit
The importance of FDA clearance
Clue Birth Control is 92% effective with typical use and 97% effective with perfect use* (1).
Typical use | Perfect use | |
---|---|---|
Clue Birth Control | 92 | 97 |
Combined pills | 93 | 99.7 |
Birth control patch | 93 | 99.7 |
Birth control ring | 93 | 99.7 |
Birth control shot | 96 | 99.8 |
IUD | 99.9 | 99.9 |
Fertility awareness methods (avg) | 88 | 95 |
Internal/ female condom | 79 | 95 |
External/ male condom | 87 | 98 |
Source: Contraceptive Technology. 2019. (Table 26-1) 21st edition.
*In the interest of providing easy-to-understand information that empowers people to make informed health decisions, when reporting efficacy figures, Clue uses the upper bound of the failure rate’s 95% confidence interval. Clinical trial results represent an estimate of the population efficacy rate. To be conservative, Clue reports the upper bound of the confidence interval from the peer-reviewed, published clinical trial of Clue Birth Control rather than the point estimate.The clinical trial found a point estimate with confidence intervals for the typical-use failure rate of 5.8% (95% confidence interval: 3.6% - 8.1%). The point estimate with confidence intervals for perfect use failure rate was 1.0% (95% confidence interval: -0.9% - 2.9%). Therefore, the marketed efficacy rates are 92% effective with typical use and 97% effective with perfect use. The Clue Birth Control clinical trial was conducted by researchers at Georgetown University in Washington, DC, and is registered at ClinicalTrials.gov as study number NCT02833922.
Clue is at the forefront of female health and heard from users that there was a need for a new fertility awareness solution. Cycle Technologies created a product called Dynamic Optimal Timing (DOT) that used a Bayesian predictive algorithm that required only period start dates to determine which days of the cycle have a high or low risk for pregnancy. The efficacy of DOT was evaluated in a full-scale clinical trial conducted by researchers at the Institute for Reproductive Health (IRH) at Georgetown University. The trial followed 718 women in the United States of America for up to 13 cycles of use. The participants were chosen to reflect the US population of women who may be in need of contraception, including a diverse array of ages, ethnicities and relationship statuses. You can read the DOT study here. Clue Birth Control incorporates DOT’s science-based algorithm so that it can be brought to the Clue audience and beyond.
Clue Birth Control is an innovative form of contraception that uses an algorithm derived from landmark studies(1)(2)(3)(4) as well as patients’ cycle data to make personalized pregnancy risk predictions. While Clue Birth Control is a fertility awareness-based method (FABM), it has higher efficacy rates than previous studies on FABMs have shown. There is a misconception about FABMs in general because their failure rate is often quoted at 24%. This data point comes from the 1995 and 2002 National Survey of Family Growth which used retrospective surveys and then pooled data for all FABMs including the outdated “rhythm method” which is actually not a FABM as it does not require any fertility awareness. This caused a negative, long-standing propagation of the idea that FABMs are ineffective as a category of contraceptives, but the reality is that this is not the case(5).
Clue Birth Control is different from other FABMs for two primary reasons: 1) it’s an FDA-cleared, evidence-based app, and 2) it’s straightforward and easy to use. The patient is only required to enter the first day of their period and check the app for their risk prediction before they have sex that may result in pregnancy.
The patient will start with 16 high risk days for their first cycle using Clue Birth Control. Clue Birth Control uses a Bayesian statistical model to predict days with a high risk of pregnancy. The model combines the cycle length data entered by the patient with what it already knows about the distributions of cycle length means and variation in the general population(6). With consistent use, the predictions become more personalized and the number of high risk days each cycle may gradually decrease to 11-13 days.
Wilcox A, Weinberg C, Armstrong E, Canfield R. Urinary Human Chorionic Gonadotropin among Intrauterine Device Users: Detection with a Highly Specific and Sensitive Assay. Fertility and Sterility. 1987 Feb;47(2):265–69.
Wilcox A, Weinberg C, Wehmann R, Armstrong E, Canfield R, Nisula B. Measuring Early Pregnancy Loss: Laboratory and Field Methods. Fertility and Sterility. 1985 Sep;44(3):366–74.
Wilcox A, Weinberg C, O’Connor J, Baird, D, Schlatterer J, Canfield R, et al. Incidence of Early Loss of Pregnancy. The New England Journal of Medicine. 1988 Jul;319(4):189–94.
World Health Organization. A Prospective Multicentre Trial of the Ovulation Method of Natural Family Planning. III. Characteristics of the Menstrual Cycle and of the Fertile Phase**Supported by the Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland. Fertility and Sterility. 1983 Dec;40(6):773-78.
Urrutia R, Polis C. Fertility awareness based methods for pregnancy prevention. BMJ. 2019 Jul;366:4245.
Li D, Heyer L, Jennings V, Smith C, Dunson D. Personalised estimation of a woman’s most fertile days. The European Journal of Contraception & Reproductive Health Care. 2016 Jun;21(4):323-28.
Clue Birth Control is for women who:
Those who would like to purchase and use Clue Birth Control must go through an in-app onboarding, which determines whether or not they meet the eligibility criteria.
Clue Birth Control is an exciting opportunity to provide patients birth control that’s both hormone free and evidence-based. It will also help patients understand their menstrual cycles.
The American College of Nurse Midwives, the American College of Obstetricians and Gynecologists and the American Academy of Family Physicians each support fertility awareness based methods of contraception as effective forms of birth control.
The United States Food and Drug Administration (FDA) has classified Clue Birth Control as a software application that can be used as contraception to prevent pregnancy. Clue has been cleared to offer Clue Birth Control to patients in the United States of America after submitting extensive information about the feature’s efficacy, the clinical evidence behind it, and the processes in place to make sure the app is maintained to the safety standards of a medical device.
Indications for use:
Clue Birth Control is a software application for contraception for women 18-45 years old, to monitor their fertility and prevent pregnancy. Clue Birth Control is suitable for women with predictable cycles.
Please find the FDA device summary here. It discusses the device itself, its technical characteristics, and a comparison to the predicate device, Natural Cycles.
Hormonal birth control has done wonders to improve the lives of people with periods worldwide and we are supportive of those who benefit from it. Users of hormonal birth control have many choices, but researchers have found that even with free accessible hormonal contraceptives, many individuals switch or discontinue hormonal birth control because of side effects1. This leaves many people with periods at risk for unintended pregnancy where in the United States approximately 42-69% of pregnancies are unintended2.
Therefore, we’ve created Clue Birth Control as a convenient alternative for people with periods to take control of their contraception without side effects.
Lynae Brayboy, MD, FACOG Clue's Chief Medical Officer
Therefore, we’ve created Clue Birth Control as a convenient alternative for people with periods to take control of their contraception without side effects.
Clue Birth Control is NOT the rhythm method. It’s a digital fertility awareness-based method that utilizes Bayesian modeling to predict ovulation based on cycle length3. It provides personalized predictive pregnancy prevention for your patients with regular periods who are not candidates for hormonal birth control or prefer not to take it. Our digital contraceptive helps the modern patient understand her/their cycle which is a vital sign for overall health.
Clue Birth Control is designed for contraception, and has been tested in a rigorous clinical trial for that purpose. In order to obtain FDA clearance to offer this feature, the US regulator examined not just the clinical trial, but subjected the entire app as well as software development processes to extensive scrutiny. Clue had to satisfy them that it's science is sound, and that its way of working, including on user privacy, is up to the standards expected of a medical device manufacturer.
Lynae Brayboy, MD, FACOG Clue's Chief Medical Officer
Learn more about the Clue app here.